Tenax Therapeutics, Inc. (TENX)
1.72
-0.04
(-2.27%)
USD |
NASDAQ |
Oct 23, 16:00
1.725
0.00 (0.00%)
After-Hours: 20:00
Tenax Therapeutics Enterprise Value : -63.02M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | -63.02M |
| October 22, 2026 | -61.74M |
| October 21, 2026 | -65.90M |
| October 20, 2026 | -65.90M |
| October 19, 2026 | -69.41M |
| October 16, 2026 | -74.52M |
| October 15, 2026 | -69.73M |
| October 14, 2026 | -68.93M |
| October 13, 2026 | -66.86M |
| October 12, 2026 | -59.51M |
| October 09, 2026 | -58.23M |
| October 08, 2026 | -58.55M |
| October 07, 2026 | -56.95M |
| October 06, 2026 | -56.31M |
| October 05, 2026 | -55.35M |
| October 02, 2026 | -54.72M |
| October 01, 2026 | -56.31M |
| September 30, 2026 | -57.59M |
| September 29, 2026 | -59.19M |
| September 28, 2026 | -58.87M |
| September 25, 2026 | -60.15M |
| September 24, 2026 | -57.59M |
| September 23, 2026 | -57.27M |
| September 22, 2026 | -55.99M |
| September 21, 2026 | -57.91M |
| Date | Value |
|---|---|
| September 18, 2026 | -57.27M |
| September 17, 2026 | -58.55M |
| September 16, 2026 | -59.83M |
| September 15, 2026 | -59.51M |
| September 14, 2026 | -58.55M |
| September 11, 2026 | -58.55M |
| September 10, 2026 | -55.67M |
| September 09, 2026 | -49.92M |
| September 08, 2026 | -54.72M |
| September 04, 2026 | -55.99M |
| September 03, 2026 | -61.11M |
| September 02, 2026 | -58.87M |
| September 01, 2026 | -60.47M |
| August 31, 2026 | -59.19M |
| August 28, 2026 | -49.92M |
| August 27, 2026 | -48.01M |
| August 26, 2026 | -50.24M |
| August 25, 2026 | -43.85M |
| August 24, 2026 | -58.87M |
| August 21, 2026 | -62.06M |
| August 20, 2026 | -61.11M |
| August 19, 2026 | -57.27M |
| August 18, 2026 | -63.66M |
| August 17, 2026 | -63.34M |
| August 14, 2026 | -60.47M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Exicure, Inc. | 4.976M |
| Century Therapeutics, Inc. | 182.55M |
| Absci Corp. | 1.378B |
| Celularity, Inc. | 97.88M |
| Cardio Diagnostics Holdings, Inc. | -0.2154M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.80M |
| Total Expenses (Quarterly) | 17.80M |
| EPS Diluted (Quarterly) | -0.35 |
| Earnings Yield | -85.76% |
| Normalized Earnings Yield | -85.75 |